{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:00:18Z","timestamp":1787828418758,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.reuma.2009.10.005","type":"journal-article","created":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T09:08:38Z","timestamp":1262336918000},"page":"72-76","source":"Crossref","is-referenced-by-count":9,"title":["Mecanismos patog\u00e9nicos de los anticuerpos antifosfol\u00edpidos"],"prefix":"10.1016","volume":"7","author":[{"given":"Carlos A.","family":"N\u00fa\u00f1ez-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cabiedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2009.10.005_bib1","first-page":"416","article-title":"Trombosis in systemic lupus erithematosus despite circulating anticoagulants","volume":"62","author":"Bowie","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.reuma.2009.10.005_bib2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(83)91267-9","article-title":"Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus","volume":"2","author":"Harris","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.reuma.2009.10.005_bib3","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.10.005_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients","volume":"68","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"Medicine"},{"key":"10.1016\/j.reuma.2009.10.005_bib5","first-page":"482","article-title":"Primary Antiphospholipid Syndrome","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.10.005_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/ard.48.5.362","article-title":"Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder","volume":"48","author":"Mackworth-Young","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2009.10.005_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine"},{"key":"10.1016\/j.reuma.2009.10.005_bib8","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Antiphospholipid antibodies are directed against complex antigen that include a lipid binding inhibitor of coagulation: \u03b22-glycoprotein I (apolipoprotein H)","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.reuma.2009.10.005_bib9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies directed not to cardiolipin but to plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.reuma.2009.10.005_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","article-title":"Anticardiolipin cofactor(s) and differencial diagnosis of autoimmune disease (letter)","volume":"336","author":"Matsuura","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.reuma.2009.10.005_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/berh.1999.0082","article-title":"The anti-phospholipid antibody syndrome: clinical and serological aspects","volume":"14","author":"Alarc\u00f3n-Segovia","year":"2000","journal-title":"Bailli\u00e8res Clin Rheumatol"},{"key":"10.1016\/j.reuma.2009.10.005_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International Consensus statement on an update of the classification criteria for definite APS","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.reuma.2009.10.005_bib13","first-page":"1899","article-title":"Clinical manifestations of the antiphospholipid s\u00edndrome in systemic lupus erythematosus patients associate more strongly with anti-\u03b22-glycoprotein I than with antiphospholipid antibodies","volume":"22","author":"Cabiedes","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.10.005_bib14","article-title":"Estandarizaci\u00f3n de un inmunoensayo de captura para la determinaci\u00f3n de los niveles s\u00e9ricos de \u03b22GP-I en sujetos sanos y en pacientes con SaF primario y asociado a LEG. Tesis de Licenciatura","author":"G\u00f3mez Suarez","year":"2005","journal-title":"UAM-INCMSZ"},{"key":"10.1016\/j.reuma.2009.10.005_bib15","first-page":"890","article-title":"Pathogenic potential of anti-phospholipid antibodies","volume":"15","author":"Alarc\u00f3n-Segovia","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.10.005_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1568-9972(02)00144-1","article-title":"Anthiphospholipid syndrome: pathogenic mechanism","volume":"2","author":"Espinoza","year":"2003","journal-title":"Autoinmmun Rev"},{"key":"10.1016\/j.reuma.2009.10.005_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0038-1650355","article-title":"Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies","volume":"75","author":"Pengo","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.reuma.2009.10.005_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2141.1993.tb03220.x","article-title":"Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitro","volume":"85","author":"Oosting","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.reuma.2009.10.005_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0038-1650220","article-title":"\u03b22-glycoprotein I modulates the anticoagulant activity of protein C on the phospholipid surface","volume":"75","author":"Mori","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.reuma.2009.10.005_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/art.1780240115","article-title":"Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis","volume":"24","author":"Cosgriff","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.10.005_bib21","first-page":"924","article-title":"Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases","volume":"27","author":"Lakos","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.10.005_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0037-1616083","article-title":"A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism","volume":"86","author":"Pasquier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.reuma.2009.10.005_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinchem\/47.6.1008","article-title":"Association between the prevalence of antibodies to beta(2)-glycoprotein I, trothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications","volume":"47","author":"Nojima","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.reuma.2009.10.005_bib24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.ATV.16.11.1319","article-title":"Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S","volume":"16","author":"Reverter","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.reuma.2009.10.005_bib25","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/1529-0131(199808)41:8<1420::AID-ART11>3.0.CO;2-U","article-title":"Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes","volume":"41","author":"Reverter","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.10.005_bib26","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1055\/s-0037-1614881","article-title":"Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome","volume":"82","author":"Dobado-Barrios","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.reuma.2009.10.005_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0038-1656365","article-title":"Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity: studies in a thrombosis model","volume":"68","author":"Oosting","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.reuma.2009.10.005_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0002-9378(12)90915-1","article-title":"Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome:a possible mechanism of thrombosis","volume":"168","author":"Branch","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.reuma.2009.10.005_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome","volume":"15","author":"Meroni","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.reuma.2009.10.005_bib30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo","volume":"99","author":"Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.reuma.2009.10.005_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/ard.61.suppl_2.ii46","article-title":"Complement activation as a mediator of antiphospholipid antibodies induced pregnancy loss and thrombosis","volume":"61","author":"Salmon","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2009.10.005_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thrombogenic effects of antiphospholipids antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1 and P-selectin","volume":"88","author":"Pierangeli","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.reuma.2009.10.005_bib33","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the Antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.reuma.2009.10.005_bib34","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.10.005_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2004.021444","article-title":"Pathogenic role of anti-beta 2 glycoprotein I antibodies in antiphospholipid associated fetal loss: characterization of beta 2 glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2 glycoprotein I antibodies in vitro","volume":"64","author":"Di Simone","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2009.10.005_bib36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.V81.5.1255.1255","article-title":"beta-2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants","volume":"81","author":"Shi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.reuma.2009.10.005_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.1780380118","article-title":"Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation: the importance of the T cell","volume":"38","author":"Blank","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.10.005_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1568-9972(03)00007-7","article-title":"Autoreactive CD4+ T cells to beta-2 glycoprotein-I in patients with antiphospholipid syndrome","volume":"2","author":"Kuwana","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2009.10.005_bib39","first-page":"30","article-title":"Proliferaci\u00f3n de c\u00e9lulas mononucleares de sangre perif\u00e9rica (CMNSP) de una paciente con SaFP inducida por \u03b22GP-I de fenotipo valina o leucina (V\/L)247","volume":"4","author":"N\u00fa\u00f1ez-\u00c1lvarez","year":"2008","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2009.10.005_bib40","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1182\/blood.V98.6.1889","article-title":"Autoreactive CD4+ T-cell clones to beta-glycoprotein I in patients with APS: preferential recognition of the major phospholipid-binding site","volume":"98","author":"Arai","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.reuma.2009.10.005_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0198-8859(99)00184-6","article-title":"Analysis of T cell responses to the beta2-glycoprotein I-derived peptide library in patients with anti-beta2-glycoprotein I antibody associated autoimmunity","volume":"61","author":"Ito","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.reuma.2009.10.005_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/art.10771","article-title":"Valine\/valine genotype at position 247 of the \u00df2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-\u00df2-glycoprotein I antibodies","volume":"48","author":"Prieto","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.10.005_bib43","first-page":"55","article-title":"Caracterizaci\u00f3n de clonas de linfocitos B obtenidos de una paciente con SaF Primario","volume":"5","author":"N\u00fa\u00f1ez-\u00c1lvarez","year":"2009","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2009.10.005_bib44","first-page":"5","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986","volume":"175","author":"Mosmann","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.reuma.2009.10.005_bib45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.reuma.2009.10.005_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2249.1999.00930.x","article-title":"Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1\/Th2 expression","volume":"117","author":"Krause","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.reuma.2009.10.005_bib47","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.4049\/jimmunol.162.11.6919","article-title":"Cellular Immunity to beta2-Glycoprotein-1 in patients with the Antiphospholipid Syndrome","volume":"162","author":"Visvanathan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.reuma.2009.10.005_bib48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00277-004-0910-7","article-title":"Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome","volume":"83","author":"Karakantza","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.reuma.2009.10.005_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","article-title":"TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss","volume":"174","author":"Berman","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.reuma.2009.10.005_bib50","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/ard.2006.063909","article-title":"Anti \u00df2GP-I antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome","volume":"66","author":"Hamid","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2009.10.005_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","article-title":"The placental bed in pregnancies complicated by primary antiphospholipid syndrome","volume":"27","author":"Stone","year":"2006","journal-title":"Placenta"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X09002459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X09002459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T09:58:47Z","timestamp":1685354327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X09002459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1699258X09002459"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2009.10.005","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}